- Home
- TARS vs SRCE Comparison
TARS vs SRCE Comparison
Compare TARS & SRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- SRCE
- Stock Information
- Founded
- TARS 2016
- SRCE 1863
- Country
- TARS United States
- SRCE United States
- Employees
- TARS N/A
- SRCE N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- SRCE Major Banks
- Sector
- TARS Health Care
- SRCE Finance
- Exchange
- TARS Nasdaq
- SRCE Nasdaq
- Market Cap
- TARS 1.8B
- SRCE 1.5B
- IPO Year
- TARS 2020
- SRCE N/A
- Fundamental
- Price
- TARS $44.83
- SRCE $64.92
- Analyst Decision
- TARS Strong Buy
- SRCE Hold
- Analyst Count
- TARS 5
- SRCE 2
- Target Price
- TARS $54.20
- SRCE $64.75
- AVG Volume (30 Days)
- TARS 1.1M
- SRCE 78.8K
- Earning Date
- TARS 11-13-2024
- SRCE 10-24-2024
- Dividend Yield
- TARS N/A
- SRCE 2.22%
- EPS Growth
- TARS N/A
- SRCE 2.45
- EPS
- TARS N/A
- SRCE 5.25
- Revenue
- TARS $129,621,000.00
- SRCE $369,012,000.00
- Revenue This Year
- TARS $852.60
- SRCE N/A
- Revenue Next Year
- TARS $74.21
- SRCE $1.11
- P/E Ratio
- TARS N/A
- SRCE $12.38
- Revenue Growth
- TARS 801.96
- SRCE 1.57
- 52 Week Low
- TARS $15.60
- SRCE $47.24
- 52 Week High
- TARS $52.99
- SRCE $67.74
- Technical
- Relative Strength Index (RSI)
- TARS 57.98
- SRCE 58.11
- Support Level
- TARS $46.22
- SRCE $57.92
- Resistance Level
- TARS $52.99
- SRCE $67.74
- Average True Range (ATR)
- TARS 3.62
- SRCE 1.73
- MACD
- TARS -0.33
- SRCE 0.38
- Stochastic Oscillator
- TARS 42.09
- SRCE 71.28
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About SRCE 1st Source Corporation
1st Source Corp along with its subsidiary offers banking services. The bank provides Commercial, Agricultural, and Real Estate Loans which are given to privately owned business clients mainly located within regional market area, Consumer Services that consists of full range of consumer banking products and services, Trust and Wealth Advisory Services and Insurance services to individuals and business clients. Its Specialty Finance Group offers financing services for construction equipment, new and pre-owned private and cargo aircraft, and various vehicle types for fleet purposes.